Sign in

Private company

Tibotec

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons3

Defunct pharmaceutical company (1994–2002)

Tibotec was a pharmaceutical company with a focus on research and development of the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002. The company is part of Johnson & Johnson Innovation Medicine business segment. The name of the company is derived from the tetrahydro-imidazo[4,5,1-jk][1,4]-benzodiazepine-2(1H)-one and -thione (TIBO) compounds discovered at the Rega Institute for Medical Research (Belgium).2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1994Founded1
  • HeadquartersBeerse1
  • Websitetibotec.de
  • Legal formprivate limited liability company1

See how the biggest companies compare on our leaderboards

Tibotec was a pharmaceutical company with a focus on research and development of the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002. The company is part of Johnson & Johnson Innovation Medicine business segment.2

Corporate structure

Tibotec is part of a group headed by Johnson & Johnson. 460 entities, 73 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

The story

In 1994, Rudi Pauwels of the Rega Institute for Medical Research founded Tibotec, together with his wife Carine Claeys, and their first co-workers Marie-Pierre de Béthune, Kurt Hertogs, and Hilde Azijn. In 1995 Paul Stoffels joined Tibotec. The company was acquired by Johnson & Johnson in April 2002, and was renamed Janssen Therapeutics in June 2011.

Tibotec provided funding for HIV treatment clinical trials at the Infectious Diseases Institute in Kampala, Uganda.

From Wikipedia’s article on Tibotec, shared under CC BY-SA 4.0.4

Subsidiaries and ownership

Parent company

From Wikidata.1

Timeline

  1. 2002Dissolved Dissolved1
  2. 1994Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4